Current vaccination status and safety of children with peripheral neuroblastoma in the real-world
peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to understand the immunization status of children with pNT in the real-world and the incidence of adverse reactions after vaccination, and to eva...
Saved in:
Published in | Frontiers in immunology Vol. 14; p. 1278258 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
08.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to understand the immunization status of children with pNT in the real-world and the incidence of adverse reactions after vaccination, and to evaluate the feasibility of vaccination and the influencing factors of vaccination.
Children with pNT treated in the Children's Hospital Affiliated to Zhejiang University from January 1, 2011 to December 1, 2021 were included. By referring to medical records, the vaccination history of the national immunization program (NIP) vaccines and the occurrence of adverse events following immunization(AEFI), current status and safety of immunization in children with pNT in the real-world were analyzed.
Among 784 children with pNT, 394 were able to obtain the history of vaccination. The overall vaccination rate of NIP vaccines was 71.49% before chemotherapy and 37.67% after chemotherapy, and the recovery time of vaccination after treatment was 16.00 (6.00,24.00) months. Age, time of tumor diagnosis and disease classification were significantly correlated with vaccination. AEFI reported an incidence of 0.23‰.
The vaccination rate of children with pNT is generally low, especially the vaccination rate after chemotherapy. The vaccination safety is good, children should be encouraged to immunize. |
---|---|
AbstractList | Backgroundperipheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to understand the immunization status of children with pNT in the real-world and the incidence of adverse reactions after vaccination, and to evaluate the feasibility of vaccination and the influencing factors of vaccination.MethodsChildren with pNT treated in the Children’s Hospital Affiliated to Zhejiang University from January 1, 2011 to December 1, 2021 were included. By referring to medical records, the vaccination history of the national immunization program (NIP) vaccines and the occurrence of adverse events following immunization(AEFI), current status and safety of immunization in children with pNT in the real-world were analyzed.ResultsAmong 784 children with pNT, 394 were able to obtain the history of vaccination. The overall vaccination rate of NIP vaccines was 71.49% before chemotherapy and 37.67% after chemotherapy, and the recovery time of vaccination after treatment was 16.00 (6.00,24.00) months. Age, time of tumor diagnosis and disease classification were significantly correlated with vaccination. AEFI reported an incidence of 0.23‰.ConclusionThe vaccination rate of children with pNT is generally low, especially the vaccination rate after chemotherapy. The vaccination safety is good, children should be encouraged to immunize. Background peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to understand the immunization status of children with pNT in the real-world and the incidence of adverse reactions after vaccination, and to evaluate the feasibility of vaccination and the influencing factors of vaccination. Methods Children with pNT treated in the Children’s Hospital Affiliated to Zhejiang University from January 1, 2011 to December 1, 2021 were included. By referring to medical records, the vaccination history of the national immunization program (NIP) vaccines and the occurrence of adverse events following immunization(AEFI), current status and safety of immunization in children with pNT in the real-world were analyzed. Results Among 784 children with pNT, 394 were able to obtain the history of vaccination. The overall vaccination rate of NIP vaccines was 71.49% before chemotherapy and 37.67% after chemotherapy, and the recovery time of vaccination after treatment was 16.00 (6.00,24.00) months. Age, time of tumor diagnosis and disease classification were significantly correlated with vaccination. AEFI reported an incidence of 0.23‰. Conclusion The vaccination rate of children with pNT is generally low, especially the vaccination rate after chemotherapy. The vaccination safety is good, children should be encouraged to immunize. peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to understand the immunization status of children with pNT in the real-world and the incidence of adverse reactions after vaccination, and to evaluate the feasibility of vaccination and the influencing factors of vaccination. Children with pNT treated in the Children's Hospital Affiliated to Zhejiang University from January 1, 2011 to December 1, 2021 were included. By referring to medical records, the vaccination history of the national immunization program (NIP) vaccines and the occurrence of adverse events following immunization(AEFI), current status and safety of immunization in children with pNT in the real-world were analyzed. Among 784 children with pNT, 394 were able to obtain the history of vaccination. The overall vaccination rate of NIP vaccines was 71.49% before chemotherapy and 37.67% after chemotherapy, and the recovery time of vaccination after treatment was 16.00 (6.00,24.00) months. Age, time of tumor diagnosis and disease classification were significantly correlated with vaccination. AEFI reported an incidence of 0.23‰. The vaccination rate of children with pNT is generally low, especially the vaccination rate after chemotherapy. The vaccination safety is good, children should be encouraged to immunize. |
Author | Liu, Yan Xu, Yuyang Li, Mingyan Zhang, Xuechao Ji, Chai Zhan, Yuxuan Shen, Heping |
AuthorAffiliation | 3 Public Health, Zhejiang University , Hangzhou , China 2 Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention , Hangzhou, Zhejiang , China 1 Department of Pediatric Hematology, Children’s Hospital, Zhejiang University School of Medicine , Hangzhou , China 4 Department of Pediatric Health Care, Children’s Hospital, Zhejiang University School of Medicine , Hangzhou , China |
AuthorAffiliation_xml | – name: 2 Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention , Hangzhou, Zhejiang , China – name: 4 Department of Pediatric Health Care, Children’s Hospital, Zhejiang University School of Medicine , Hangzhou , China – name: 3 Public Health, Zhejiang University , Hangzhou , China – name: 1 Department of Pediatric Hematology, Children’s Hospital, Zhejiang University School of Medicine , Hangzhou , China |
Author_xml | – sequence: 1 givenname: Heping surname: Shen fullname: Shen, Heping organization: Department of Pediatric Hematology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China – sequence: 2 givenname: Yuyang surname: Xu fullname: Xu, Yuyang organization: Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China – sequence: 3 givenname: Yuxuan surname: Zhan fullname: Zhan, Yuxuan organization: Public Health, Zhejiang University, Hangzhou, China – sequence: 4 givenname: Yan surname: Liu fullname: Liu, Yan organization: Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China – sequence: 5 givenname: Xuechao surname: Zhang fullname: Zhang, Xuechao organization: Department of Expanded Program on Immunization, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang, China – sequence: 6 givenname: Mingyan surname: Li fullname: Li, Mingyan organization: Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China – sequence: 7 givenname: Chai surname: Ji fullname: Ji, Chai organization: Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38259480$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkctu3CAUhlGVqrk0L9BFxbIbT83FGK-qatQ2kSJ1067RMRzHRLaZAk6Utw-TmUYJG9DhP9-5_OfkZAkLEvKJ1RshdPd18PO8bnjNxYbxVvNGvyNnTClZCc7lyav3KblM6a4uR3ZCiOYDORVF30ldnxHYrjHikuk9WOsXyD4sNGXIa6KwOJpgwPxIw0Dt6CdXpPTB55HuMPrdiBEmuuAaQz9BymEG6heaR6QRYaoeQpzcR_J-gCnh5fG-IH9__vizvapufv-63n6_qazkda64EIgoXdsqBayXHLq-t6CBiw4bhJ53rmW8iBk6ZFIK5UBzrME2TAkUF-T6wHUB7swu-hniowngzXMgxFsDMXs7oSllOlCCMxiEbDnTSjpodC2FdrJWe9a3A2u39jM6WxZUJn0Dffuz-NHchnvDal3WrHghfDkSYvi3Yspm9sniNMGCYU2Gd6zVSmgmipQfpDaGlCIOL3VYbfZem2evzd5rc_S6JH1-3eFLyn9nxRMzT6nO |
Cites_doi | 10.1016/s0022-3476(77)80364-8 10.3760/cma.j.cn112140-20200525-00540 10.1002/eji.202048541 10.3390/cancers12020519 10.1016/s2352-4642(20)30312-6 10.19914/j.cjvi.2012.05.006 10.5152/TurkArchPediatr.2021.21090 10.1002/pbc.28565 10.1016/j.bbmt.2017.11.012 10.3390/cancers13092096 10.1002/1097-0142(197709)40:3<994::aid-cncr2820400305>3.0.co;2-5 10.1053/j.seminhematol.2009.03.010 10.3760/cma.j.cn311365-20210913-00331 10.1016/s2352-4642(22)00315-7 10.3760/cma.j.cn112140-20200729-00761 10.13820/j.cnki.gdyx.20191339 10.19914/j.cjvi.2020.01.020 10.3389/fimmu.2021.696816 10.3760/cma.j.cn112140-20200307-00195 10.3969/j.issn.1007-9572.2012.36.091 10.3969/j.issn.1000-8179.2012.15.002 10.1002/pbc.28319 10.1002/ped4.12213 10.19914/j.CJVI.2022019 10.1080/21645515.2015.1012015 10.1016/s0242-6498(04)94018-7 10.1002/ped4.12214 10.1186/s12957-023-03011-y 10.1001/jamanetworkopen.2021.18508 10.1007/s11912-022-01270-8 10.1542/peds.60.6.805 10.3969/j.issn.1672-5301.2021.07.013 10.3969/j.issn.1673-5323.2014.02.007 10.19914/j.CJVI.2022041 10.1016/j.eimc.2016.09.003 10.1097/00043426-199809000-00008 10.1111/apa.15275 10.3389/fonc.2020.572413 10.1002/pbc.21070 10.1200/jco.2006.08.8799 10.1155/2014/707691 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji. Copyright © 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji |
Copyright_xml | – notice: Copyright © 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji. – notice: Copyright © 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fimmu.2023.1278258 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
EndPage | 1278258 |
ExternalDocumentID | oai_doaj_org_article_e4d9a6321af34721864da580438d406e 10_3389_fimmu_2023_1278258 38259480 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CGR CUY CVF DIK EBS ECM EIF EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM OK1 PGMZT RIG RNS RPM AAYXX CITATION 7X8 ITC 5PM |
ID | FETCH-LOGICAL-c420t-233eee4d7766a1b42a9bbca8a239e5eab29d712c421ede14436da82e0ac5163e3 |
IEDL.DBID | RPM |
ISSN | 1664-3224 |
IngestDate | Thu Sep 05 15:43:28 EDT 2024 Tue Sep 17 21:29:59 EDT 2024 Fri Aug 16 05:34:28 EDT 2024 Thu Sep 26 18:51:08 EDT 2024 Sat Sep 28 08:09:28 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | security immunization rates children peripheral neuroblastoma immunization program |
Language | English |
License | Copyright © 2024 Shen, Xu, Zhan, Liu, Zhang, Li and Ji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c420t-233eee4d7766a1b42a9bbca8a239e5eab29d712c421ede14436da82e0ac5163e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Jennifer T. Grier, University of South Carolina, United States These authors have contributed equally to this work and share first authorship Reviewed by: Manik Kuvalekar, Baylor College of Medicine, United States Edited by: Elizabeth S. Fernandes, Pelé Pequeno Príncipe Research Institute, Brazil |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800462/ |
PMID | 38259480 |
PQID | 2917863813 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e4d9a6321af34721864da580438d406e pubmedcentral_primary_oai_pubmedcentral_nih_gov_10800462 proquest_miscellaneous_2917863813 crossref_primary_10_3389_fimmu_2023_1278258 pubmed_primary_38259480 |
PublicationCentury | 2000 |
PublicationDate | 2024-01-08 |
PublicationDateYYYYMMDD | 2024-01-08 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-08 day: 08 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2024 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Lundberg (B6) 2022; 24 Zhao (B18) 2014; 2 Ruan (B43) 2021; 59 Xiangshi (B13) 2021; 39 Jankowski (B1) 2019; 74 Su (B7) 2020; 58 Fernández-Prada (B47) 2018; 36 Wei (B25) 2019; 40 Chen (B27) 2021; 19 Orgel (B32) 1977; 40 Szanto (B14) 2020; 12 Tamura (B15) 2020; 10 Szanto (B16) 2021; 13 Yuan (B30) 2020; 58 Wang (B36) 2020; 26 He (B39) 2021; 48 Hu (B40) 2022; 40 Liu (B46) 2023; 21 Peuchmaur (B3) 2004; 24 Furlong (B38) 2023; 7 Hu (B9) 2015; 11 Kostinov (B28) 2021; 12 Lázničková (B19) 2020; 50 Guilcher (B21) 2021; 5 Patel (B31) 2020; 67 Su (B8) 2020; 4 Mustafa (B12) 1998; 20 Bailey (B45) 2009; 46 Chung (B17) 1977; 90 Zhang (B41) 2022; 28 Marquis (B11) 2021; 4 Jin (B2) 2020; 4 Nassin (B20) 2018; 24 Cesaro (B44) 2014; 2014 Olkinuora (B22) 2013; 129 Ye (B24) 2022; 28 De Bernardi (B4) 2008; 26 Bao (B10) 2013; 51 Castagnola (B23) 2007; 49 Shi Ch (B5) 2012; 39 Diallo (B33) 2020; 109 Ocak (B29) 2021; 56 Cao (B35) 2012; 18 Choi (B37) 2020; 67 Ye (B34) 2022; 28 Wu (B26) 2012; 15 Izawa (B42) 1977; 60 |
References_xml | – volume: 90 year: 1977 ident: B17 article-title: Abnormalities of the immune system in children with neuroblastoma related to the neoplasm and chemotherapy publication-title: J Pediatr doi: 10.1016/s0022-3476(77)80364-8 contributor: fullname: Chung – volume: 58 start-page: 796 year: 2020 ident: B7 article-title: Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center publication-title: Zhonghua Er Ke Za Zhi doi: 10.3760/cma.j.cn112140-20200525-00540 contributor: fullname: Su – volume: 50 year: 2020 ident: B19 article-title: Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence publication-title: Eur J Immunol doi: 10.1002/eji.202048541 contributor: fullname: Lázničková – volume: 12 year: 2020 ident: B14 article-title: Monitoring immune responses in neuroblastoma patients during therapy publication-title: Cancers (Basel) doi: 10.3390/cancers12020519 contributor: fullname: Szanto – volume: 5 year: 2021 ident: B21 article-title: Immune function in childhood cancer survivors: a Children's Oncology Group review publication-title: Lancet Child Adolesc Health doi: 10.1016/s2352-4642(20)30312-6 contributor: fullname: Guilcher – volume: 48 year: 2021 ident: B39 article-title: Parents' hesitancy towards childhood vaccination and its influencing factors in 260 cases publication-title: Fudan J (Medical Edition) contributor: fullname: He – volume: 18 year: 2012 ident: B35 article-title: Investigation and analysis of the vaccination rate of the expanded National Immunization Program in China publication-title: China Vaccines Immunization. doi: 10.19914/j.cjvi.2012.05.006 contributor: fullname: Cao – volume: 56 year: 2021 ident: B29 article-title: Hepatitis B vaccination in children with ongoing cancer treatment: A safety and efficacy study of super-accelerated vaccination scheme publication-title: Turk Arch Pediatr doi: 10.5152/TurkArchPediatr.2021.21090 contributor: fullname: Ocak – volume: 67 year: 2020 ident: B37 article-title: Vaccination in pediatric cancer survivors: Vaccination rates, immune status, and knowledge regarding compliance publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.28565 contributor: fullname: Choi – volume: 24 year: 2018 ident: B20 article-title: Immune reconstitution following autologous stem cell transplantation in patients with high-risk neuroblastoma at the time of immunotherapy publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2017.11.012 contributor: fullname: Nassin – volume: 13 year: 2021 ident: B16 article-title: Immune monitoring during therapy reveals activitory and regulatory immune responses in high-risk neuroblastoma publication-title: Cancers (Basel) doi: 10.3390/cancers13092096 contributor: fullname: Szanto – volume: 40 year: 2022 ident: B40 article-title: Immunization strategies for children with neurological diseases publication-title: J Clin Pediatr contributor: fullname: Hu – volume: 40 year: 1977 ident: B32 article-title: Antibody responses in normal infants and in infants receiving chemotherapy for congenital neuroblastoma publication-title: Cancer doi: 10.1002/1097-0142(197709)40:3<994::aid-cncr2820400305>3.0.co;2-5 contributor: fullname: Orgel – volume: 46 year: 2009 ident: B45 article-title: Infections in pediatric patients with hematologic Malignancies publication-title: Semin Hematol doi: 10.1053/j.seminhematol.2009.03.010 contributor: fullname: Bailey – volume: 39 year: 2021 ident: B13 article-title: Investigation of serum measles antibody level in children with tumor after chemotherapy publication-title: Chin J Infect Dis doi: 10.3760/cma.j.cn311365-20210913-00331 contributor: fullname: Xiangshi – volume: 7 start-page: 199 year: 2023 ident: B38 article-title: Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer publication-title: Lancet Child Adolesc Health doi: 10.1016/s2352-4642(22)00315-7 contributor: fullname: Furlong – volume: 59 year: 2021 ident: B43 article-title: Preliminary practice of multidisciplinary cooperative immunization model in children with hematologic tumors publication-title: Chin J Pediatr doi: 10.3760/cma.j.cn112140-20200729-00761 contributor: fullname: Ruan – volume: 40 start-page: 2367 year: 2019 ident: B25 article-title: Analysis of 213 children immunization consultation clinics publication-title: Guangdong Med doi: 10.13820/j.cnki.gdyx.20191339 contributor: fullname: Wei – volume: 26 year: 2020 ident: B36 article-title: Analysis of current situation and influencing factors of non-immunization program vaccine in China publication-title: Chin J Vaccines Immunol doi: 10.19914/j.cjvi.2020.01.020 contributor: fullname: Wang – volume: 12 year: 2021 ident: B28 article-title: Vaccination against diphtheria and tetanus as a way to activate adaptive immunity in children with solid tumors publication-title: Front Immunol doi: 10.3389/fimmu.2021.696816 contributor: fullname: Kostinov – volume: 58 year: 2020 ident: B30 article-title: Efficacy and safety of hepatitis B re-vaccination in children after completion of chemotherapy and(or) hematopoietic stem cell transplantation publication-title: Zhonghua Er Ke Za Zhi doi: 10.3760/cma.j.cn112140-20200307-00195 contributor: fullname: Yuan – volume: 15 year: 2012 ident: B26 article-title: Immunization program vaccine coverage rate in children with cerebral palsy publication-title: Chin Gen Pract doi: 10.3969/j.issn.1007-9572.2012.36.091 contributor: fullname: Wu – volume: 39 start-page: 1008 year: 2012 ident: B5 article-title: Pathological classification and early diagnosis of neuroblastoma in children publication-title: Chin Oncol clinic doi: 10.3969/j.issn.1000-8179.2012.15.002 contributor: fullname: Shi Ch – volume: 67 year: 2020 ident: B31 article-title: Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.28319 contributor: fullname: Patel – volume: 4 year: 2020 ident: B2 article-title: Diagnosis and treatment of infantile Malignant solid tumors in beijing, China: A multicenter 10-year retrospective study publication-title: Pediatr Investig doi: 10.1002/ped4.12213 contributor: fullname: Jin – volume: 28 start-page: 94 year: 2022 ident: B34 article-title: Surveillance of routine immunization coverage rate of National Immunization Program vaccines among school-age children in China from 2016 to 2019 publication-title: Chin J Vaccines Immunol doi: 10.19914/j.CJVI.2022019 contributor: fullname: Ye – volume: 11 year: 2015 ident: B9 article-title: Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2015.1012015 contributor: fullname: Hu – volume: 129 year: 2013 ident: B22 article-title: Immune deficiency and infections in children having cancer publication-title: Duodecim contributor: fullname: Olkinuora – volume: 74 year: 2019 ident: B1 article-title: Epidemiology of childhood cancer, a single-center study (1985-2016) publication-title: Rev Med Liege contributor: fullname: Jankowski – volume: 24 year: 2004 ident: B3 article-title: Peripheral neuroblastic tumors: anatomo pathological classification publication-title: Ann Pathol doi: 10.1016/s0242-6498(04)94018-7 contributor: fullname: Peuchmaur – volume: 51 year: 2013 ident: B10 article-title: Recent incidences and trends of childhood Malignant solid tumors in Shanghai, 2002-2010 publication-title: Zhonghua Er Ke Za Zhi contributor: fullname: Bao – volume: 4 year: 2020 ident: B8 article-title: Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China publication-title: Pediatr Investig doi: 10.1002/ped4.12214 contributor: fullname: Su – volume: 21 start-page: 130 year: 2023 ident: B46 article-title: Metastasis pattern and prognosis in children with neuroblastoma publication-title: World J Surg Oncol doi: 10.1186/s12957-023-03011-y contributor: fullname: Liu – volume: 28 start-page: 94 year: 2022 ident: B24 article-title: Surveillance of routine immunization coverage rate of National Immunization Program vaccines among school-age children in China from 2016 to 2019 publication-title: Vaccines Immunization China doi: 10.19914/j.CJVI.2022019 contributor: fullname: Ye – volume: 4 start-page: e2118508 year: 2021 ident: B11 article-title: Seroprevalence of measles and mumps antibodies among individuals with cancer publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2021.18508 contributor: fullname: Marquis – volume: 24 year: 2022 ident: B6 article-title: Neuroblastoma heterogeneity, plasticity, and emerging therapies publication-title: Curr Oncol Rep doi: 10.1007/s11912-022-01270-8 contributor: fullname: Lundberg – volume: 60 year: 1977 ident: B42 article-title: Application of a live varicella vaccine in children with acute leukemia or other Malignant diseases publication-title: Pediatrics doi: 10.1542/peds.60.6.805 contributor: fullname: Izawa – volume: 19 year: 2021 ident: B27 article-title: Investigation on vaccination of children with congenital heart disease publication-title: Chin Cardiovasc Res doi: 10.3969/j.issn.1672-5301.2021.07.013 contributor: fullname: Chen – volume: 2 year: 2014 ident: B18 article-title: Analysis of immune function indexes in children with neuroblastoma before and after chemotherapy publication-title: Chin J Pediatr Hematol Oncol doi: 10.3969/j.issn.1673-5323.2014.02.007 contributor: fullname: Zhao – volume: 28 year: 2022 ident: B41 article-title: Surveillance of suspected abnormal vaccination responses in China in 2020 publication-title: Vaccines immunization China doi: 10.19914/j.CJVI.2022041 contributor: fullname: Zhang – volume: 36 start-page: 78 year: 2018 ident: B47 article-title: Adapting immunisation schedules for children undergoing chemotherapy publication-title: Enferm Infecc Microbiol Clin (Engl Ed) doi: 10.1016/j.eimc.2016.09.003 contributor: fullname: Fernández-Prada – volume: 20 year: 1998 ident: B12 article-title: Immune recovery in children with Malignancy after cessation of chemotherapy publication-title: J Pediatr Hematol Oncol doi: 10.1097/00043426-199809000-00008 contributor: fullname: Mustafa – volume: 109 year: 2020 ident: B33 article-title: Vaccination coverage of children with chronic diseases is inadequate especially for specifically recommended vaccines publication-title: Acta Paediatr doi: 10.1111/apa.15275 contributor: fullname: Diallo – volume: 10 year: 2020 ident: B15 article-title: Low multiplication value of absolute monocyte count and absolute lymphocyte count at diagnosis may predict poor prognosis in neuroblastoma publication-title: Front Oncol doi: 10.3389/fonc.2020.572413 contributor: fullname: Tamura – volume: 49 year: 2007 ident: B23 article-title: Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.21070 contributor: fullname: Castagnola – volume: 26 year: 2008 ident: B4 article-title: Retrospective study of childhood ganglioneuroma publication-title: J Clin Oncol doi: 10.1200/jco.2006.08.8799 contributor: fullname: De Bernardi – volume: 2014 year: 2014 ident: B44 article-title: Guidelines on vaccinations in paediatric haematology and oncology patients publication-title: BioMed Res Int doi: 10.1155/2014/707691 contributor: fullname: Cesaro |
SSID | ssj0000493335 |
Score | 2.3973627 |
Snippet | peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this study is to... Background peripheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this... Backgroundperipheral neuroblastic tumors (pNT) have high incidence and mortality, and infants are prone to various infectious diseases. The purpose of this... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1278258 |
SubjectTerms | Child children Humans Immunization immunization program Immunization Programs immunization rates Immunology Infant Neuroblastoma - therapy peripheral neuroblastoma security Vaccination - adverse effects Vaccines |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et-uLCN6k2ibpI0cVZRH0pOAtTJsprrhdcbuC_95J0l12RfDitQ3N8E3b-SbJfMPYqSDkbZ7LCAuNkUqtjijK6ajKQaJCiNFr6d0_ZP0ndfecPs-1-nJnwoI8cADuApXVkEmRQC1V7jooKQtp4TawLAUj9H_fJJ1Lpl4D75VSpqFKhrIwfVEPhsPJuWsWfp4ICouux_tcJPKC_b-xzJ-HJeeiz-06W-toI78M5m6wJWw22UpoJPm1xaCTWeKfUFWDsMDHXa3QZMyhsXwMNbZffFTzafE2dwuw3Mkce12BN-6FLUvi0u1oCHzQcGKGnBjlW-RFVbfZ0-3N43U_6ponRJUScRsJKREJvDzPMkhKJUCXZQUFCKkxRSiFtnkiaHCCFimtkpmFQmAMVUocDeUOW25GDe4xHleZQIp1kNVK5fSQUgJSZiOTyioa2WNnUyDNe9DIMJRbONiNh9042E0He49dOaxnI52-tb9AXjed181fXu-xk6mnDH0PbpMDGhxNxkZQ_lnQTyUhs3aD52ZTSZpfqyLusWLBpwu2LN5pBi9ec9sdxXR1vPv_Yf0BWyVElF_JKQ7ZcvsxwSPiNm157F_jb6bx-AY priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access(OpenAccess) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VVkhcqlI-urRURuKGsiS2kzgHhAqiqiqVEyv1Zk3iCWy1m7S7WcT-e8ZOtmJRuXBN7Nh6Y2fe-OMNwFvJyLs8VxGZgiKduiJiL1dEVY6KNGFMQUvv6mt2MdGX1-n1DmzSHQ0ALh8M7Xw-qcliNv51t_7IE_6DjzjZ376vp_P5auzzgI8TyR4vNY9gT2ql_Yi_Guj-Tc-GlVJpf3fmH1W3_FOQ8X-Ie_59hPIPn3R-APsDmRRnvfWfwg41h_C4Ty-5fgY4iC-Jn1hV037ZT_gbRKulwMaJJdbUrUVbi82VbuGXZYUXPw5qAzMR5C5LZthdO0cxbQTzRcE8cxYFqdXnMDn_8u3zRTSkVIgqLeMukkoRkWbrZBkmpZZYlGWFBqUqKCUsZeHyRHLhhBxxsKUyh0ZSjFXKzI3UC9ht2oaOQMRVJok9IGa11jl_pFRIHO-opHKaS47g3QZIe9srZ1iOODzsNsBuPex2gH0EnzzW9yW96nV40C6-22ESWe54gZmSCdZK5z6blnaYGr-Z6ZiY0AjebCxleZb4rQ9sqF0treSo1PCvJuFuvewtd9-U4vYLbeIRmC2bbvVl-00z_RGUuP0BTX-799X_Vz2GJ4yDDqs65gR2u8WKXjPP6crTMHh_A6tEAIg priority: 102 providerName: Scholars Portal |
Title | Current vaccination status and safety of children with peripheral neuroblastoma in the real-world |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38259480 https://search.proquest.com/docview/2917863813 https://pubmed.ncbi.nlm.nih.gov/PMC10800462 https://doaj.org/article/e4d9a6321af34721864da580438d406e |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBVJoNBLadOvbdqgQm_Fu7Yk2_IxDU1DYUsPDexNjKVx67K2Q9YbyL_PSLbDbukpFx1s2RIzsueNNPOGsU-CJO_yXEaoC4xU6oqIrFwR2RwkKoQYA5fe8kd2eaW-r9LVAcumXJgQtG_Let6um3lb_wmxldeNXUxxYoufy3MfF-eTKheH7DCXcsdH_ztgXillOmTIkAdWLKq6abZzXyh8nggyib6--44VCmT9_0OY_wZK7liei-fs2QgZ-dkwtRfsANtj9mQoInn3ksFIscRvwdp62NzjPk9ou-HQOr6BCvs73lV8StzmfvOVe4rjwCmw5oHUsiQc3XcN8LrlhAo5ocl1FAhVX7Gri6-_zi-jsXBCZJWI-0hIiYiKdJBlkJRKQFGWFjQIWWCKUIrC5Ymgzgk6JJdKZg60wBhsSvgM5Wt21HYtvmU8tplAsnOQVUrl9JJSApJXIxPrFPWcsc-TIM31wI9hyK_wYjdB7MaL3Yxin7EvXtYPPT23dbjQ3fw2o4YNTbyATIoEKqlyXzNLOUi1P7J0BD9wxj5OmjL0LfgDDmix226MIN9T0w8loWm9GTT3MJSk8Qul4xnTezrdm8v-HVp-gW97Wm7vHv_oCXtKclBh70a_Z0f9zRY_EJrpy9OwC0Dtt1VC7VLp07Cc7wGBFfrh |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYILb8ryNBI3lGxiO68jVFQLdCsOrejNmjgTCN0kVTdBKr-esZNUuxUXuMZO4njGmW_smW8Yeyto5oskkR6mGXoqKjKPrFzmmQQkKoQAHZfe8ihenKjPp9HpDounXBgXtG_yym9Wtd9UP1xs5Xlt5lOc2Pzrct_GxdmkyvkNdpMWrEg2vPSfA-qVUkZDjgz5YNm8rOq6922pcD8UZBRthfcNO-To-v-GMa-HSm7YnoN77Ns06iHk5Mzvu9w3v68ROv77Z91nd0c4yt8P7Q_YDjYP2a2hQOXlIwYjfRP_BcZUw8YhtzlI_ZpDU_A1lNhd8rbkU1I4txu73NInO76CFXeEmTlh9K6tgVcNJ8TJCamuPEfW-pidHHw83l94Y1EGzygRdJ6QEhEVyTeOIcyVgCzPDaQgZIYRQi6yIgkFdQ6xQHLXZFxAKjAAExH2Q_mE7TZtg08ZD0wskGwoxKVSCT0kl4DkMcnQFIp6zti7SUT6fODe0OSzWIFqJ1BtBapHgc7YByvFq56WN9tdaC--63GaNQ08g1iKEEqpEluPSxUQpfY4tCBogzP2ZtIBTevMHp5Ag22_1oL82pR-ViENa2_QiatXkQpa1ptgxtItbdkay3YL6YDj8p5k_uz_b33Nbi-Ol4f68NPRl-fsDs2JcntE6Qu22130-JJQU5e_ckvkD0SgGk4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSlPEuXp5G4obxs53WEwqo8WvVApUocrIkzgcAmu-omSOXXM3aSarfi1GsySRzPOPONM_MNY28EzXyZptLDLEdPxWXukZfLPZOCRIUQouPSOzpODk_V57P4bMyqXI9pla0par9dNH5b_3S5lavGBFOeWHBydGDz4mxRZbAqq-Amu0WLVuQbkfqvAflKKeOhTobisDyo6qbpfdsu3I8EOUbb5X3DFznK_v_hzKvpkhv-Z36PfZ9GPqSd_Pb7rvDN3yukjtd7tftsd4Sl_N0g84DdwPYhuz00qrx4xGCkceJ_wJh62EDkthapX3NoS76GCrsLvqz4VBzO7QYvtzTKjrdgwR1xZkFYvVs2wOuWE_LkhFgXniNtfcxO5x-_HRx6Y3MGzygRdp6QEhEV6TlJICqUgLwoDGQgZI4xQiHyMo0ECUdYIoVtMikhExiCiQkDotxjO-2yxX3GQ5MIJF8KSaVUSjcpJCBFTjIypSLJGXs7qUmvBg4OTbGLVap2StVWqXpU6oy9t5q8lLT82e7A8vyHHqda08BzSKSIoJIqtX25VAlxZn-LlgRxcMZeT3agab3ZnyjQ4rJfa0HxbUYfrYiG9WSwi8tHkRla9ptwxrIti9kay_YZsgPH6T3p_en1L33F7px8mOuvn46_PGN3aUqU2yrKnrOd7rzHFwSeuuKlWyX_AATCHM4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+vaccination+status+and+safety+of+children+with+peripheral+neuroblastoma+in+the+real-world&rft.jtitle=Frontiers+in+immunology&rft.au=Shen%2C+Heping&rft.au=Xu%2C+Yuyang&rft.au=Zhan%2C+Yuxuan&rft.au=Liu%2C+Yan&rft.date=2024-01-08&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=14&rft_id=info:doi/10.3389%2Ffimmu.2023.1278258&rft.externalDBID=PMC10800462 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |